CDC Travelers' Health offers information to assist travelers and their health-care providers in deciding the vaccines, medications, and other measures necessary to prevent illness and injury during international travel.
This report provides an update to the international situation as of March 12, 2010. The World Health Organization (WHO) continues to report updated 2009 H1N1 flu-associated laboratory-confirmed cases and deaths on its Web page.
CDC has again updated its estimates of the total number of 2009 H1N1 cases, hospitalizations and deaths in the United States since April, 2009. The new estimates incorporate an additional four weeks of flu data from the previous estimates released on February 12, 2010.
During week 9 (February 28 - March 6, 2010), influenza activity remained at approximately the same levels as last week in the U.S. 174 (5.1%) specimens tested by U.S. World Health Organization (WHO) and National Respiratory and Enteric Virus Surveillance System (NREVSS) collaborating laboratories and reported to CDC/Influenza Division were positive for influenza.
FluView reports that for the week of February 21 - February 27, 2010, flu activity in the United States was relatively low, with most flu continuing to be caused by 2009 H1N1. Flu activity, caused by either 2009 H1N1 or seasonal flu viruses, may rise and fall, but is expected to continue for weeks. It’s possible that the United States could experience another wave of flu activity caused by either 2009 H1N1 or seasonal influenza.
This is a letter developed jointly by the American College Health Association (ACHA) and CDC intended for distribution to colleges and universities across the country prior to Spring Break. The message to students is: Don't let influenza spoil your plans for Spring Break. Take the opportunity to get vaccinated before leaving for Spring Break and protect yourself, friends and family against 2009 H1N1 flu.
This report provides an update to the international situation as of February 27, 2010. The World Health Organization (WHO) continues to report updated 2009 H1N1 flu-associated laboratory-confirmed cases and deaths on its Web page.
During week 8 (February 21-27, 2010), influenza activity remained at approximately the same levels as last week in the U.S. 263 (6.4%) specimens tested by U.S. World Health Organization (WHO) and National Respiratory and Enteric Virus Surveillance System (NREVSS) collaborating laboratories and reported to CDC/Influenza Division were positive for influenza.
FluView reports that for the week of February 21 - February 27, 2010, flu activity in the United States was relatively low, with most flu continuing to be caused by 2009 H1N1. Flu activity, caused by either 2009 H1N1 or seasonal flu viruses, may rise and fall, but is expected to continue for weeks. It's possible that the United States could experience another wave of flu activity caused by either 2009 H1N1 or seasonal influenza.
Graphical representations of CDC's latest estimates for 2009 H1N1 cases, hospitalizations and deaths in the United States, April 2009 - January 16, 2010.
This report provides an update to the international situation as of February 20, 2010. The World Health Organization (WHO) continues to report updated 2009 H1N1 flu-associated laboratory-confirmed cases and deaths on its Web page.
During week 7 (February 14-20, 2010), influenza activity remained at approximately the same levels as last week in the U.S. 185 (4.4%) specimens tested by U.S. World Health Organization (WHO) and National Respiratory and Enteric Virus Surveillance System (NREVSS) collaborating laboratories and reported to CDC/Influenza Division were positive for influenza.
FluView reports that for the week of February 14 - February 20, 2010, flu activity in the United States was relatively low, with most flu continuing to be caused by 2009 H1N1. Flu activity, caused by either 2009 H1N1 or seasonal flu viruses, may rise and fall, but is expected to continue for weeks. It's possible that the United States could experience another wave of flu activity caused by either 2009 H1N1 or seasonal influenza.
Questions and answers related to underlying health conditions among adults and children hospitalized with 2009 H1N1 in the United States from April 2009 through February 16, 2010.
Target audience: State health planners
This document is intended to provide PHER funded grantees with information regarding the reduction of vaccine inventory and allocation at the McKesson 2009 H1N1 vaccine/ancillary supply distribution depots.
During week 6 (February 7-13, 2010), influenza activity remained at approximately the same levels as last week in the U.S. 129 (3.5%) specimens tested by U.S. World Health Organization (WHO) and National Respiratory and Enteric Virus Surveillance System (NREVSS) collaborating laboratories and reported to CDC/Influenza Division were positive for influenza.
FluView reports that for the week of February 7 - February 13, 2010, flu activity in the United States was relatively low, with most flu continuing to be caused by 2009 H1N1. Flu activity, caused by either 2009 H1N1 or seasonal flu viruses, may rise and fall, but is expected to continue for weeks. It's possible that the United States could experience another wave of flu activity, or more likely, localized outbreaks of 2009 H1N1 in communities that have been relatively unaffected by illness thus far, or where 2009 H1N1 vaccination rates may have been lower.
This Q&A provides updated information about flu-related hospitalizations and deaths in the United States reported to CDC from April 2009 - January 30, 2010.
During week 5 (January 31-February 6, 2010), influenza activity remained at approximately the same levels as last week in the U.S. 206 (4.8%) specimens tested by U.S. World Health Organization (WHO) and National Respiratory and Enteric Virus Surveillance System (NREVSS) collaborating laboratories and reported to CDC/Influenza Division were positive for influenza.
FluView reports that for the week of January 31 - February 6, 2010, flu activity in the United States remained about the same as during the previous week. Flu activity is relatively low at this time, with most flu continuing to be caused by 2009 H1N1. Flu activity, caused by either 2009 H1N1 or seasonal flu viruses, may rise and fall, but it is expected to continue for several more months.
These questions and answers summarize the current understanding of the impact of 2009 H1N1 and seasonal influenza virus on Hispanics/Latinos, describe some of the barriers to uptake of 2009 H1N1 and seasonal influenza vaccines, and outline potential strategies for improving health and increasing vaccine coverage in Hispanic/Latino communities.
The abbreviated Primary Care Office Template was developed by SME's in primary care, public health and emergency management during a stakeholder meeting in August 2009. Utilizing this template, primary care offices will be able to rapidly (within 1-5 days) develop a pandemic influenza plan and be encouraged to become integrated into community planning.
This report provides an update to the international situation as of January 31, 2010. The World Health Organization (WHO) continues to report updated 2009 H1N1 flu-associated laboratory-confirmed cases and deaths on its Web page.
During week 4 (January 24-30, 2010), influenza activity remained at approximately the same levels as last week in the U.S.
119 (3.2%) specimens tested by U.S. World Health Organization (WHO) and National Respiratory and Enteric Virus Surveillance System (NREVSS) collaborating laboratories and reported to CDC/Influenza Division were positive for influenza.
FluView reports that for the week of January 24-30, 2010, flu activity in the United States remained about the same as during the previous week. Flu activity is relatively low at this time, with most flu continuing to be caused by 2009 H1N1. Flu activity, caused by either 2009 H1N1 or seasonal flu viruses, may rise and fall, but it is expected to continue for several more months.
All lots of monovalent 2009 H1N1 influenza vaccine in pre-filled syringes manufactured by Sanofi Pasteur, not included in the two earlier recalls, should now be administered by February 15, 2010 regardless of the expiration imprinted on the package.
In recent testing of its influenza A (H1N1) monovalent vaccine, Sanofi Pasteur found five distributed lots of single-dose, pre-filled syringe pediatric (0.25 mL) vaccine and one distributed lot of single-dose pre-filled syringe for older children and adults (0.5 mL) vaccine had potency below pre-specified limits.
As of January 7, 2010, the cumulative pro rata allocation is approximately 136 million doses of 2009 H1N1 vaccine. As of January 5, 2010, approximately 111 million doses have been shipped, so supplies of 2009 H1N1 vaccine available to be administered are ample. Although the 2009 H1N1 vaccine was initially prioritized to certain target groups, due to the increase in supply most jurisdictions are now making vaccine available for everyone who wishes to receive it.
This document includes updated information about late season flu vaccination, including who is recommended, where to find vaccine, and why it should still be taken seriously.
This document includes updated information about late season flu vaccination, including who is recommended, where to find vaccine, and why it should still be taken seriously.
This document includes updated information about late season flu vaccination, including who is recommended, where to find vaccine, and why it should still be taken seriously.
This document provides a suggested step-by-step approach to communicating pediatric-related information on pandemic influenza at the community level. The document goal is to provide community planners "talking points" for discussions on a coordinated approach to communication in their community.
This report provides an update to the international situation as of January 29, 2010. The World Health Organization (WHO) continues to report updated 2009 H1N1 flu-associated laboratory-confirmed cases and deaths on its Web page.
During week 2 (January 10-16, 2010), influenza activity decreased slightly in the U.S. 120 (3.7%) specimens tested by U.S. World Health Organization (WHO) and National Respiratory and Enteric Virus Surveillance System (NREVSS) collaborating laboratories and reported to CDC/Influenza Division were positive for influenza.
An update from the Tribal CERC/Pandemic Influenza Course which is a day and half training course that offers a combination of influenza communication tabletop exercises and informative group discussions.
Overall flu activity in the United States decreased again slightly during the week of January 10-16, 2010, as reported in FluView. Though flu activity, caused by either 2009 H1N1 or seasonal flu viruses, may rise and fall, it is expected to continue for several more months.
In an open letter to the American people, several health care provider and public health organizations encouraged Americans to get the H1N1 vaccine. This letter emphasizes that the H1N1 vaccine is safe, effective, and the best way to protect against 2009 H1N1 flu. Originally, 32 organizations signed on to this letter; however, since publication, several groups have joined this effort.
During week 1 (January 3-9, 2010), influenza activity continued to decrease in the U.S. 139 (3.6%) specimens tested by U.S. World Health Organization (WHO) and National Respiratory and Enteric Virus Surveillance System (NREVSS) collaborating laboratories and reported to CDC/Influenza Division were positive for influenza.
Overall flu activity in the United States decreased during the week of January 3-9, 2010, as reported in FluView. Though flu activity, caused by either 2009 H1N1 or seasonal flu viruses, may rise and fall, it is expected to continue for several more months. Supply and availability of the 2009 H1N1 vaccine have increased dramatically, CDC is now encouraging everyone who has been patiently waiting to receive the 2009 H1N1 vaccine to get vaccinated at this time.
This document provides information to state/local immunization programs regarding options for reporting certain criminal, fraud and abuse matters relating to the 2009 H1N1 influenza vaccine and ancillary supplies.
In an Open Letter to the American People, over thirty major health care provider and public health organizations encouraged Americans to get the H1N1 vaccine. This letter emphasizes that the H1N1 vaccine is safe, effective, and the best way to protect against the flu.
This report provides an update to the international situation as of January 8, 2010. The World Health Organization (WHO) continues to report updated 2009 H1N1 flu-associated laboratory-confirmed cases and deaths on its Web page.
During week 52 (December 27, 2009-January 2, 2010), influenza activity decreased slightly in the U.S.
161 (3.9%) specimens tested by U.S. World Health Organization (WHO) and National Respiratory and Enteric Virus Surveillance System (NREVSS) collaborating laboratories and reported to CDC/Influenza Division were positive for influenza.
Flu Activity: Overall flu activity in the United States decreased slightly during the week of December 27-January 2, 2010, as reported in FluView. Though flu activity, caused by either 2009 H1N1 or seasonal flu viruses, may rise and fall, it is expected to continue for several more months.
Vaccination: CDC recommends influenza vaccination as the first and most important step in protecting against the flu. The week of January 10-16, 2010 marks this season’s National Influenza Vaccination Week (NIVW), a national observance to highlight the importance of continuing influenza vaccination beyond the holiday season. Because supplies of the 2009 H1N1 vaccines have increased dramatically, CDC is now encouraging everyone who has been patiently waiting to receive the 2009 H1N1 vaccine to get vaccinated at this time.
People with diabetes are more likely to get flu-related complications like pneumonia and even be hospitalized or die from the flu than other people. Influenza may also interfere with blood glucose management. This fact sheet contains important information for diabetics.
CDC is aware that pregnant women, parents of young children, and others may have questions about the safety of thimerosal in vaccines against 2009 H1N1 flu. The following fact sheet provides some information to help in making decisions.
This report provides an update to the international situation as of January 4, 2010. The World Health Organization (WHO) continues to report updated 2009 H1N1 flu-associated laboratory-confirmed cases and deaths on its Web page.
During week 51 (December 20-26, 2009), influenza activity decreased slightly in the U.S. 154 (3.9%) specimens tested by U.S. World Health Organization (WHO) and National Respiratory and Enteric Virus Surveillance System (NREVSS) collaborating laboratories and reported to CDC/Influenza Division were positive for influenza.Four states reported geographically widespread influenza activity, 13 states reported regional influenza activity, the District of Columbia, Puerto Rico, and 19 states reported local influenza activity, Guam and 13 states reported sporadic influenza activity, and one state reported no influenza activity, the U.S. Virgin Islands did not report.
Overall flu activity decreased slightly in the United States during the week of December 20-26, 2009, as reported in FluView. The number of states reporting widespread flu activity decreased from 7 to 4. to doctors for influenza-like illness increased, although the proportion of tests for influenza that were positive continued to decline and the overall hospitalization rates for this season were unchanged from the previous week. Flu-associated deaths among all ages increased from the previous week, but fewer deaths in children were reported compared to the prior week (4 versus 9). Flu is unpredictable and activity can rise and fall throughout the season, but flu is likely to continue for months, caused by either 2009 H1N1 viruses or regular seasonal flu viruses.
This podcast discusses the use of antiviral drugs for the treatment and prevention of influenza, including 2009 H1N1, during the 2009-2010 influenza season.
To assess intent to receive influenza vaccines among children and adults, during August 2009, the North Carolina Center for Public Health Preparedness conducted a community assessment in two counties to measure knowledge of and intent to receive H1N1 and seasonal influenza vaccines.
During week 50 (December 13-19, 2009), influenza activity continued to decrease in the U.S. 306 (6.9%) specimens tested by U.S. World Health Organization (WHO) and National Respiratory and Enteric Virus Surveillance System (NREVSS) collaborating laboratories and reported to CDC/Influenza Division were positive for influenza.
Flu activity continued to decline in the United States during the week of December 13-19, 2009, as reported in FluView. The number of states reporting widespread flu activity decreased from 11 to 7. Visits to doctors for influenza-like illness, flu-associated hospitalizations, and flu-associated deaths all declined from the previous week. Flu is unpredictable and activity can rise and fall throughout the season, but flu is is likely to continue for months caused by either 2009 H1N1 viruses or regular seasonal flu viruses. In addition to seasonal flu vaccine, a vaccine against the 2009 H1N1 virus has been produced and is the best way to protect against the pandemic virus. Supplies of this vaccine are increasing and many places have opened up vaccination to anyone who wants it.
This document provides several questions and answers regarding the recent MedImmune voluntary Non-Safety-Related Recall of Specific Lots of Nasal Spray Vaccine for 2009 H1N1 Influenza
This document provides information on the National H1N1 Flu Survey (NHFS) which was conducted to determine who has received the 2009 H1N1 influenza vaccine since its release.
Revised fact sheet for people 65 and older to reflect the fact that supplies of the vaccine to protect against the 2009 H1N1 virus are increasing and many places have opened up vaccination to anyone who wants it. CDC is now encouraging those who have been patiently waiting to receive the 2009 H1N1 vaccine, including people 65 and older, to get vaccinated depending on local supply.
Revised Fact Sheet for Patients to reflect new amendment for rRT-PCR Swine Flu Panel (also referred to as Swine Flu Test Kit), authorized by FDA on December 18, 2009.
Revised Fact Sheet for Health Care Providers to reflect new amendment for rRT-PCR Swine Flu Panel (also referred to as Swine Flu Test Kit), authorized by FDA on December 18, 2009.
Revised EUA Letter to reflect new amendment for rRT-PCR Swine Flu Panel (also referred to as Swine Flu Test Kit), authorized by FDA on December 18, 2009.
Supplies of the vaccines to protect against the 2009 H1N1 virus are increasing. Providers are encouraged to open up vaccination to anyone who wants it as soon as the needs of the initial prioritized populations have been met. Many places have already opened up vaccination to anyone who wants it and CDC is encouraging people who have been patiently waiting to receive the 2009 H1N1 vaccine to get vaccinated now. Influenza is unpredictable, but flu is expected to continue for months, caused by either 2009 H1N1 viruses or regular seasonal flu viruses. This vaccine is the best way to protect against the 2009 H1N1 pandemic virus
This report provides an update to the international situation as of December 18, 2009. The World Health Organization (WHO) continues to report updated 2009 H1N1 flu-associated laboratory-confirmed cases and deaths on its Web page.
During the week of December 6, 2009-December 12, 2009, flu activity declined in the United States as reported in FluView. The number of states reporting widespread flu activity decreased from 14 to 11.
These interim recommendations refer to patients who are severely immunosuppressed as a result of receiving treatment for malignancies; or as a result of receiving treatment related to solid organ or hematopoietic stem cell transplants; or as a result of autoimmune conditions and treatment. In addition to this guidance, there are documents available for caregivers of adult and adolescent HIV-infected patients as well as for patients with rheumatological diseases
This document features several questions and answers regarding the recent Sanofi Pasteur voluntary recall of the H1N1 Pediatric (0.25 mL, for 6-35 month olds) vaccine in pre-filled syringes.
This is a quick overview of what pregnant women need to know about 2009 H1N1 flu. It is in downloadable format for use in doctor's offices or by individuals.
This is a quick overview of what pregnant women need to know about 2009 H1N1 flu. It is in downloadable format for use in doctor's offices or by individuals.
During the week of November 29-December 5, 2009, flu activity declined in the United States as reported in FluView. The number of states reporting widespread flu activity decreased from 25 to 14.
As of December 8, 2009, there have been 33,490 laboratory-confirmed influenza-associated hospitalizations and 1,445 deaths in the U.S. from August 30 to December 5, 2009.
These questions and answers summarize the current understanding of the impact of 2009 H1N1 and seasonal influenza virus on African Americans, describe some of the barriers to uptake of 2009 H1N1 and seasonal influenza vaccines, and outline potential strategies for improving health and increasing vaccine coverage in African American communities.
This document provides answers to frequently asked questions about H1N1 vaccine. It also has updated information on vaccine project areas and distribution at the state and local level.
Information regarding use of intravenous peramivir under an emergency use authorization. Information on availability of renal dosing for peramivir. Updated oseltamivir dosing instructions for children younger than 1 year of age based on weight.
Will you know what to do if someone in your home gets the flu? This new online guide from CDC provides step-by-step instructions on how to care for someone sick in your home. Learn what you can do to help your family this flu season.
This report provides an update to the international situation as of December 4, 2009. The World Health Organization (WHO) continues to report updated 2009 H1N1 flu-associated laboratory-confirmed cases and deaths on its Web page.
Significant increases in the proportion of hospitalized adults and children being treated with influenza antiviral drugs have been noted during the 2009 H1N1 pandemic compared to the proportion of adults and children that have been treated with flu antiviral drugs during past seasonal influenza epidemics.
During the week of November 22-28, 2009, flu activity declined in the United States as reported in FluView. The number of states reporting widespread flu activity decreased from 32 to 25 and visits to doctors for influenza-like illness declined nationally from the previous week. In addition, flu-related hospitalizations and deaths continue to decline, but remain high compared to what is expected for this time of year.
As of December 2, 2009, there have been 31,320 laboratory-confirmed influenza-associated hospitalizations and 1,336 deaths in the U.S. from August 30 to November 28, 2009.
This podcast, intended for parents, discusses high-risk medical conditions that put children at risk for flu complications and how to protect children from the flu.
This document provides instructions for caregivers on how to open and mix Tamiflu® capsules with a thick sweetened liquid for children who cannot swallow capsules.
This document provides updated guidance regarding management of influenza-like illness (ILI) before, during and after a flight, including personal protective measures for the crew, and reporting of ILI to CDC Quarantine Stations.
This report provides an update to the international situation as of November 27, 2009. The World Health Organization (WHO) continues to report updated 2009 H1N1 flu-associated laboratory-confirmed cases and deaths on its Web page.
During the week of November 15-21, 2009, influenza activity decreased in the United States as reported in FluView. Flu activity is widespread in 32 states. Nationally, visits to doctors for influenza-like-illness decreased sharply from last week. Flu-related hospitalizations and deaths remain higher than expected for this time of year.
This document has been revised to include additional information about Medicare and Medicaid payments made for H1N1 vaccine administration in settings outside the provider office.
Each day, CDC will now provide the data on 2009 H1N1 vaccine doses allocated, ordered, and shipped in XML format, making it easier for states and other partners to use the data for their own purposes.
This page was updated November 25, 2009 to include new information on antiviral availability and additional information that may be useful for pharmacists working in both outpatient and inpatient settings.
This page contains links to information about the 2009 H1N1 virus, including the origins of the virus and recent reports of small changes to the virus.
These images provide a 3D graphical representation of the biology and structure of a generic influenza virus, and are not specific to the 2009 H1N1 virus.
This document has been revised to include updated information related to FDA approval of the GSK 2009 H1N1 monovalent influenza vaccine to be used in persons ages 18 years old and older and the expanded use of CSL 2009 H1N1 monovalent influenza vaccine to younger age groups.
Reviews the guidance for emergency shelters, including planning for flu, steps to take to reduce the risk of influenza transmission, signs and symptoms of flu, and people at higher risk for flu complications.
This updated guidance expands upon previously posted guidance entitled, "Interim Guidance for Homeless and Emergency Shelters on the Novel Influenza A (H1N1) Virus" dated June 16, 2009. It provides detailed recommendations for emergency shelters on planning, staffing, and arranging the shelter to reduce the risk of influenza transmission.
This report provides an update to the international situation as of November 20, 2009. The World Health Organization (WHO) continues to report updated 2009 H1N1 flu-associated laboratory-confirmed cases and deaths on its Web page.
During the week of November 8-14, 2009, influenza activity decreased slightly in the United States as reported in FluView. Flu activity is widespread in 43 states. Nationally, visits to doctors for influenza-like-illness declined from last week, but are still higher than expected for this time of year. Flu-related hospitalizations and deaths have declined slightly, but are still very high nation-wide compared to what is expected for this time of year.
This table for healthcare providers and planners provides information related to administration of 2009 H1N1 vaccine with seasonal influenza and other vaccines.
This table for healthcare providers and planners provides information related to spacing between the two doses of 2009 H1N1 Vaccine for children 6 months through 9 years of age.
This table for healthcare providers and planners provides information related to spacing between the two doses of 2009 H1N1 vaccine for children 6 months through 9 years of age and for administration of 2009 H1N1 vaccine with seasonal influenza and other vaccines.
During the week of November 8-14, 2009, influenza activity decreased slightly in the United States as reported in FluView. Flu activity is widespread in 43 states. Nationally, visits to doctors for influenza-like-illness declined from last week, but are still higher than expected for this time of year. Flu-related hospitalizations and deaths have declined slightly, but are still very high nation-wide compared to what is expected for this time of year.
On November 11, 2009, the FDA expanded the approved use of CSL's seasonal and 2009 H1N1 monovalent influenza vaccines to include children aged 6 months and older. Both vaccines had previously been approved only for use in adults, aged 18 years and older.
What is invasive pneumococcal disease? What does CDC know about invasive pneumococcal disease among people who get 2009 H1N1 or seasonal influenza? What is Active Bacterial Core surveillance (ABCs)?
People with certain types of disability have a higher risk of getting flu-related complications, such as pneumonia. The 2009 H1N1 Flu Information for People with Disabilities and Their Caregivers or Personal Assistants is now available to the public.
This report provides an update to the international situation as of November 13, 2009. The World Health Organization (WHO) continues to report updated 2009 H1N1 flu-associated laboratory-confirmed cases and deaths on its Web page.
During the week of November 1-7, 2009, influenza activity remained high in the United States as reported in FluView. Flu activity is widespread in 48 states. Nationally, visits to doctors for influenza-like-illness declined slightly from last week, but are still very high. Flu-related hospitalizations and deaths continue to increase and are very high nation-wide compared to what is expected for this time of year.
During the week of November 1-7, 2009, influenza activity continued to increase in the United States as reported in FluView. Flu activity is now widespread. Nationwide, visits to doctors for influenza-like-illness are increasing steeply and are now higher than what is seen at the peak of many regular flu seasons. In addition, flu-related hospitalizations and deaths continue to go up nation-wide and are above what is expected for this time of year.
This revised document updates the information for employed women so that it is consistent with the most recent infection control guidance posted by CDC.
CDC has developed a method to provide an estimated range of the total number of 2009 H1N1 cases, hospitalizations and deaths in the United States since April, 2009, as well as a breakdown of these estimates by age groups.
Two different influenza vaccines are available this influenza season, and many people will be recommended to receive both the seasonal influenza vaccine and the 2009 influenza A (H1N1) 2009 monovalent vaccine (referred to in this document as 2009 H1N1 monovalent influenza vaccine). Below are some practical considerations for use of influenza vaccines. This information is only intended to address the current flu season and might change as the situation unfolds. This information is not intended to be applied to routine use during future seasonal influenza vaccination efforts.
This updated guidance replaces previously posted guidance entitled "Consideration Regarding Novel H1N1 Flu Virus in Obstetric Setting", dated July 6, 2009. Two steps are provided to guide the clinical management of labor, delivery and postpartum care of a mother with suspected or confirmed maternal infection with 2009 H1N1 flu, and care of the newborn.
Pneumococcal infections have been identified as an important complication in severe and fatal cases of 2009 H1N1 influenza virus infection. CDC has written a letter to providers urging them to make sure all their adult patients with indications have received the pneumococcal polysaccharide vaccine.
During the week of October 25-31, 2009, influenza activity remained high in the United States as reported in FluView. Flu activity is widespread in 48 states. Nationally, visits to doctors for influenza-like-illness declined slightly from last week, but are still very high. Flu-related hospitalizations and deaths continue to increase and are very high nation-wide compared to what is expected for this time of year.
The 2009 pandemic H1N1 influenza virus continues to be the dominant influenza virus in circulation in the U.S. The benefit of antiviral treatment is greatest when it is initiated as early as possible in the clinical course.
The 2009 pandemic H1N1 influenza virus continues to be the dominant influenza virus in circulation in the U.S. The benefit of antiviral treatment is greatest when it is initiated as early as possible in the clinical course.
What animals can be infected with the 2009 H1N1 virus? How do companion animals become infected with 2009 H1N1? Can I get 2009 H1N1 influenza from my pet? Is there a vaccine available for my pet?
Influenza viruses can rarely be passed from people to live pigs and from live pigs to people. This interim guidance provides information on precautions for protecting workers exposed to pigs with known or suspected flu infection on production premises AND for protecting pigs from people with flu.
This document provides health care providers, clinicians, and vaccine planners with information about 2009 H1N1 monovalent influenza vaccine dosage, administration and storage.
Quicklinks for information regarding Peramivir IV and to FDA's Guidance to Pharmacies on Advance Compounding of Tamiflu Oral Suspension to Provide for Multiple Prescriptions.
